Edition:
United States

OptiNose Inc (OPTN.OQ)

OPTN.OQ on NASDAQ Stock Exchange Global Select Market

11.39USD
19 Oct 2018
Change (% chg)

$-0.03 (-0.26%)
Prev Close
$11.42
Open
$11.42
Day's High
$11.84
Day's Low
$11.29
Volume
71,265
Avg. Vol
96,200
52-wk High
$30.00
52-wk Low
$9.78

Chart for

About

OptiNose, Inc. is a pharmaceutical company. The Company is focused on the development and commercialization of products for patients treated by ear, nose and throat, or ENT, and allergy specialists. The Company’s products candidates include XHANCE (Nasal Polyps), XHANCE (Chornic Sinusitis) OPN-300, OPN-021, and other. The... (more)

Overall

Beta: --
Market Cap(Mil.): $439.00
Shares Outstanding(Mil.): 41.22
Dividend: --
Yield (%): --

Financials

  OPTN.OQ Industry Sector
P/E (TTM): -- 119.85 32.14
EPS (TTM): -2.43 -- --
ROI: -59.61 1.96 12.83
ROE: -- 1.12 14.95

Earnings vs. Estimates